<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               <BR>                  14 CLINICAL STUDIES<BR>               <BR>               <BR>                  The safety and efficacy of Carisoprodol Tablets for the relief of acute, idiopathic mechanical low back pain was evaluated in two, 7-day, double blind, randomized, multicenter, placebo controlled, U.S. trials (Studies 1 and 2).  Patients had to be 18 to 65 years old and had to have acute back pain (≤ 3 days of duration) to be included in the trials.  Patients with chronic back pain; at increased risk for vertebral fracture (e.g., history of osteoporosis); with a history of spinal pathology (e.g., herniated nucleus pulposis, spondylolisthesis or spinal stenosis); with inflammatory back pain, or with evidence of a neurologic deficit were excluded from participation.  Concomitant use of analgesics (e.g., acetaminophen, NSAIDs, tramadol, opioid agonists), other muscle relaxants, botulinum toxin, sedatives (e.g., barbiturates, benzodiazepines, promethazine hydrochloride), and anti-epileptic drugs was prohibited.<BR>                  In Study 1, patients were randomized to one of two treatment groups (i.e., Carisoprodol Tablets 350 mg, or placebo). In the study, patients received study medication three times a day and at bedtime for seven days.<BR>                  The primary endpoints were the relief from starting backache and the global impression of change, as reported by patients, on Study Day 3.  Both endpoints were scored on a 5-point rating scale from 0 (worst outcome) to 4 (best outcome) in the study. <BR>                  The proportion of patients who used concomitant acetaminophen, NSAIDs, tramadol, opioid agonists, other muscle relaxants, and benzodiazepines was similar in the treatment groups.<BR>                  The results for the primary efficacy evaluations in the acute, low back pain studies are presented in Table 3.<BR>                  <BR>                     Table 3. Results of the Primary Efficacy Endpointsa in Study 1<BR>                  <BR>                  <BR><BR><table xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><BR>                     <col/><BR>                     <col/><BR>                     <col/><BR>                     <col/><BR>                     <col/><BR>                     <col/><BR>                     <tbody><BR>                        <tr><BR>                           <td align="center">&#160;<content styleCode="bold">Parameter</content><BR>                           </td><BR>                           <td align="center">&#160;&#160; </td><BR>                           <td align="center">&#160;<content styleCode="bold">Placebo</content><BR>                           </td><BR>                           <td align="center">&#160;&#160; </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;&#160; </td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;<content styleCode="bold">Number of Patients</content><BR>                           </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;n=269</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;<content styleCode="bold">Relief for Starting Backache, Mean (SE)<sup>b</sup><BR>                              </content><BR>                           </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;1.4(0.1)</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;Difference between Carisoprodol Tablets&#160;and Placebo, Mean (SE)<sup>b </sup>(95% CI)</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;<content styleCode="bold">Global Impression of Change, Mean (SE)<sup>b</sup><BR>                              </content><BR>                           </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;1.9 (0.1)</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;Difference between Carisoprodol and Placebo, Mean (SE)<sup>b </sup>(95% CI)</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td colspan="6"><BR>                              <paragraph><BR>                                 <sup>a </sup>The primary efficacy endpoints (Relief from Starting Backache and Global Impression of Change) were assessed by the patients on Study Day #3. These endpoints were scored on a 5-point rating scale from 0 (worst outcome) to 4 (best outcome).&#160;<br/><BR>                                 <sup>b </sup>Mean is the least squared mean and SE is the standard error of the mean.&#160; </paragraph><BR>                              <paragraph>Patients treated with Carisoprodol Tablets&#160;experienced improvement in function as measured by the Roland-Morris Disability Questionnaire (RMDQ) score on Days 3 and 7.</paragraph><BR>                              <br/>&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center" colspan="4"><BR>                              <content styleCode="bold">&#160;</content><BR>                              <br/><BR>                              <content styleCode="bold">&#160;</content><BR>                              <br/><BR>                              <br/>&#160; <br/><BR>                              <content styleCode="bold">&#160;</content><BR>                              <br/>&#160; </td><BR>                           <td align="center"/><BR>                           <td align="center">&#160; </td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center" colspan="2">&#160;<br/><BR>                              <br/>&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center" colspan="3">&#160;<br/><BR>                              <br/>&#160;<br/><BR>                           </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;<br/><BR>                           </td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center"/><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                        <tr><BR>                           <td align="center" colspan="2">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                           <td align="center">&#160;</td><BR>                        </tr><BR>                     </tbody><BR>                  </table><BR>               <BR><BR><BR><BR>               <BR>            <BR>         </P></DIV></HTML>